ArticleMolecular cancer research : MCR2020

Dominant-Negative ATF5 Compromises Cancer Cell Survival by Targeting CEBPB and CEBPD.

Xiaotian Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.